Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Less than Half of New Diabetes Patients Achieve A1C Goals Posted: Sunday, March 11, 2012

Those starting with lower A1C levels more likely to achieve A1C goal within five months.

New First in Class Diabetes Drug Shows Efficacy, Lower Risk for Hypoglycemia Posted: Saturday, March 10, 2012

A novel investigational drug called TAK-875 (Takeda), the first in its class to be tested in diabetes, provides glycemic control in patients with type 2 diabetes with less risk for hypoglycemia compared with standard treatment.

Stop Using Sulfonylureas? Posted: Saturday, March 10, 2012

The ACP has issued a clinical practice guideline regarding use of oral agents in type 2 diabetes entitled, "Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians."

Decaffeinated Coffee Might Boost Brain Power for Type 2 Diabetes Posted: Monday, February 13, 2012

Decaf coffee was found to improve glucose energy metabolism in the brain in mouse studies.

New ACP Guidelines for Type 2 Diabetes Treatment Posted: Sunday, February 12, 2012

Metformin should be the initial drug for most patients with type 2 diabetes refractory to lifestyle modifications, with a second drug added if needed, according to a new clinical practice guideline from the ACP.

Metformin May Help Protect Women against Pancreatic Cancer Posted: Sunday, February 05, 2012

A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease.

FDA Approves BYDUREON™ -- The First Once-Weekly Treatment for Type 2 Diabetes Posted: Sunday, January 29, 2012

Once weekly Bydureon will be available in February at the approximate coast of $323 dollars a month which will include 4 injection syringes using 1 per week.

Intranasal Insulin Boosts Cognitive Function Posted: Saturday, January 28, 2012

Pooled data suggest that intranasal insulin may have a positive effect on cognition in both impaired and normal subjects.

For T2DM, the Quality of Guidelines on Oral Meds Varies Dramatically Posted: Saturday, January 07, 2012

According to the results of a systematic review, not all practice guidelines on oral medications for type 2 diabetes are consistent with available evidence, and guideline quality varies widely.

CDC: Hep B Vaccine Needed for Diabetic Adults Posted: Monday, January 02, 2012

Diabetic adults should be vaccinated against hepatitis B virus (HBV) as soon as possible after the diabetes diagnosis is made.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.